| [1] |
贺丽英，孙蕴，要文娟，等.2010-2016年中国老年人骨质疏松症患病率Meta分析[J].中国骨质疏松杂志，2016,22(12):1590-1596. DOI:10.3969/j.issn.1006-7108.2016.12.019.
|
| [2] |
Marchesi JR，Adams DH，Fava F，et al. The gut microbiota and host health: a new clinical frontier[J]. Gut,2016,65(2):330-339. DOI:10.1136/gutjnl-2015-309990.
|
| [3] |
陈晨，王邦茂，冯淑芝，等.肠道菌群对骨代谢影响的研究进展[J].中国骨质疏松杂志,2018,24(12):1640-1643. DOI:10.3969/j.issn. 1006-7108.2018.12.017.
|
| [4] |
McCabe L, Britton RA, Parameswaran N. Prebiotic and probiotic regulation of bone health: Role of the intestine and its microbiome[J]. Curr Osteoporos Rep,2015,13(6):363-371. DOI:10.1007/s11914-015-0292-x.
|
| [5] |
G Sharon，N Grag，J Debelius，et al. Specialized metabolites from the microbiome in health and disease[J]. Cell Metab,2014,20(5):719-730. DOI:10.1016/j.cmet.2014.10.016.
|
| [6] |
Smith PM，Howitt MR，Panikov N，et al. The microbial metabolites,short-chain fatty acids,regulate colonic Treg cell homeostasis[J]. Science, 2013, 341(6145):569-573. DOI:10.1126/science.1241165.
|
| [7] |
Charles JF，Ermann J，Aliprantis AO. The intestinal microbiome and skeletal fitness: Connecting bugs and bones[J]. Clin Immunol,2015,159(2):163-169. DOI:10.1016/j.clim.2015.03.019.
|
| [8] |
Lucas S,Omata Y,Hofmann J, et al. Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss[J]. Nat Commun, 2018, 9(1):55. DOI:10.1038/s41467-017-02490-4.
|
| [9] |
Smith BJ, Lerner MR,Bu SY, et al. Systematic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation[J]. Bone, 2006, 38(3):378-386. DOI:10.1002/jbmr.2887.
|
| [10] |
Park OJ, Kim J, Yang J, et al. Muramyl dipeptide,a shared structural motif of peptidoglycans, is a novel inducer of bone formation through induction of Runx2[J]. J Bone Miner Res, 2019, 34(5):1455-1468. DOI:10.1002/jbmr.3706.
|
| [11] |
邬佳瑜，李玲，胡予.肠道菌群与骨质疏松的关系[J].生命的化学,2023,42(12):2200-2207. DOI:10.13488/j.smhx.20220413.
|
| [12] |
Klara S,Cecilia E, Petra H, et al. The gut microbiota regulates bone mass in mice[J]. J Bone Miner Res,2012,27(6):1357-1367. DOI:10.1002/jbmr.1588.
|
| [13] |
Lin X，Xiong D，Peng YQ，et al. Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives [J]. Clin Interv Aging,2015,10:1017-1033. DOI:10.1016/j.cell.2015.02.047.
|
| [14] |
O’Toole PW，Jeffery IB. Gut microbiota and aging[J]. Science,2015,350(6265):1214-1215. DOI: 10.1126/science.aac8469.
|
| [15] |
Alessandro de Sire，Roberto de Sire，Claudio Curci，et al. Role of Dietary Supplements and Probiotics in Modulating Microbiota and Bone Health：The Gut-Bone Axis [J]. Cell, 2022, 11,743. DOI:10.3390/CELLS11040743.
|
| [16] |
钟礼伦，彭颖君，梁桂平，等。肠道菌群、免疫与骨关节炎关系研究进展[J].实用骨科杂志,2019,25(10):916-919. DOI:10.13795/j.cnki.sgkz.2019.10.013.
|
| [17] |
谭钢，徐静，康成为，等.益生菌影响骨质疏松相关机制的研究进展[J].吉林医学，2022,43(2):536-539. DOI：10.3969/j.issn.1004-0412.2022.02.099
|
| [18] |
Ii JY. Sex steroid deficiency-associated bone loss is micro-biota dependant and prevented by probiotics[J]. J Clin Inv,2016,126:2049-63. DOI:10.1002/jbmr.1588.
|
| [19] |
Zhenzheng W，Kaiwen X，Maosheng B，et al. Probiotics protect mice from CoCrMo particles-induced osteolysis [J]. Int J Nanomedicine,2017,12:5387-5397. DOI:10.1371/journal.pone.0092368.
|
| [20] |
Wang Y，Cheng Z，Elalieh HZ,et al. IGF-1R signaling in chondrocytes modulates growth plate development by interacting with the PTHrP/Ihh pathway[J]. J Bone Miner Res,2011,26(7):1437-1446. DOI:10.1002/jbmr.359.
|
| [21] |
唐亨方，姚啸生，戚晓楠.补肾健脾类中药改善肠道菌群治疗骨质疏松症的机制分析[J].实用中医内科杂志,2021,35(3):1-4. DOI:10.13729/j.issn.1671-7813.z20200659.
|
| [22] |
钟小惠，张烽，曹宏，等.肠道菌群对骨代谢性疾病作用机制的研究进展[J]. 医学综述, 2021, 27(7):1265-1271. DOI:10.3969/j.issn.10064-2084.2021.07.004.
|
| [23] |
Li P, Ji B, Luo H, et al. One-year supplementation with Lactobacillus reuteri ATCC PTA 6475 counteracts a degradation of gut microbiota in older women with low bone mineral density[J]. NPJ Biofilms Microbiomes. 2022 Oct 19;8(1):84. DOI: 10.1038/s41522-022-00348-2.
|
| [24] |
Chevalier C, Kieser S, Çolakoğlu M, et al. Warmth Prevents Bone Loss Through the Gut Microbiota[J]. Cell Metab. 2020 Oct 6;32(4):575-590.e7. DOI: 10.1016/j.cmet.2020.08.012.
|
| [25] |
Zhang RK, Yan K, Chen HF, et al. Anti-osteoporotic drugs affect the pathogenesis of gut microbiota and its metabolites: a clinical study[J]. Front Cell Infect Microbiol, 2023 Jul 4;13:1091083. DOI: 10.3389/fcimb.2023.1091083.
|
京ICP备08002354号-3
